|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruix J and Sherman M: Management of
hepatocellular carcinoma. Hepatology. 42:1208–1236. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee TK, Castilho A, Ma S and Ng IO: Liver
cancer stem cells: Implications for a new therapeutic target. Liver
Int. 29:955–965. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu Z, Pestell TG, Lisanti MP and Pestell
RG: Cancer stem cells. Int J Biochem Cell Biol. 44:2144–2151. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta PB, Chaffer CL and Weinberg RA:
Cancer stem cells: Mirage or reality? Nat Med. 15:1010–1012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oates JE, Grey BR, Addla SK, Samuel JD,
Hart CA, Ramani VA, Brown MD and Clarke NW: Hoechst 33342 side
population identification is a conserved and unified mechanism in
urological cancers. Stem Cells Dev. 18:1515–1522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suetsugu A, Nagaki M, Aoki H, Motohashi T,
Kunisada T and Moriwaki H: Characterization of CD133+
hepatocellular carcinoma cells as cancer stem/progenitor cells.
Biochem Biophys Res Commun. 351:820–824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Patrawala L, Calhoun-Davis T,
Schneider-Broussard R and Tang DG: Hierarchical organization of
prostate cancer cells in xenograft tumors: The CD44+alpha2-beta1+
cell population is enriched in tumor-initiating cells. Cancer Res.
67:6796–6805. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K
and Hirohashi S: Dysadherin, a cancer-associated cell membrane
glycoprotein, down-regulates E-cadherin and promotes metastasis.
Proc Natl Acad Sci USA. 99:365–370. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nam JS, Hirohashi S and Wakefield LM:
Dysadherin: A new player in cancer progression. Cancer Lett.
255:161–169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin LX and Tang ZY: Recent progress in
predictive biomarkers for metastatic recurrence of human
hepatocellular carcinoma: A review of the literature. J Cancer Res
Clin Oncol. 130:497–513. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Royds JA and Iacopetta B: p53 and disease:
When the guardian angel fails. Cell Death Differ. 13:1017–1026.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan J, Li R, Zhang R, Liu HL, Zhang N,
Zhang FQ and Dou KF: Effect of Bcl-2 and Bax on survival of side
population cells from hepatocellular carcinoma cells. World J
Gastroenterol. 13:6053–6059. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ,
Oh SH, Kong G, Kang KS and Nam JS: Dysadherin can enhance
tumorigenesis by conferring properties of stem-like cells to
hepatocellular carcinoma cells. J Hepatol. 54:122–131. 2011.
View Article : Google Scholar
|
|
18
|
Shimamura T, Yasuda J, Ino Y, Gotoh M,
Tsuchiya A, Nakajima A, Sakamoto M, Kanai Y and Hirohashi S:
Dysadherin expression facilitates cell motility and metastatic
potential of human pancreatic cancer cells. Cancer Res.
64:6989–6995. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta (CT)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Kim RJ, Kim SR, Roh KJ, Park SB, Park JR,
Kang KS, Kong G, Tang B, Yang YA, Kohn EA, et al: Ras activation
contributes to the maintenance and expansion of Sca-1pos cells in a
mouse model of breast cancer. Cancer Lett. 287:172–181. 2010.
View Article : Google Scholar
|
|
21
|
Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang
J: The side population in human lung cancer cell line NCI-H460 is
enriched in stem-like cancer cells. PLoS One. 7:e333582012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic.
Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bosch FX, Ribes J and Borràs J:
Epidemiology of primary liver cancer. Semin Liver Dis. 19:271–285.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee TK, Castilho A, Cheung VC, et al:
CD24(+) liver tumor-initiating cells drive self-renewal and tumor
initiation through STAT3-mediated NANOG regulation. Cell Stem Cell.
9:50–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and mullerian
inhibiting substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar
|
|
27
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Goodell MA and Brenner MK: A distinct 'side population' of cells in
human tumor cells: Implications for tumor biology and therapy. Cell
Cycle. 4:203–205. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bunting KD, Zhou S, Lu T and Sorrentino
BP: Enforced P-glycoprotein pump function in murine bone marrow
cells results in expansion of side population stem cells in vitro
and repopulating cells in vivo. Blood. 96:902–909. 2000.PubMed/NCBI
|
|
29
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Norwood K, Wang RY, Hirschmann-Jax C,
Andreeff M, Brenner MK, Goodell MA and Wulf GG: An in vivo
propagated human acute myeloid leukemia expressing ABCA3. Leuk Res.
28:295–299. 2004. View Article : Google Scholar
|
|
31
|
Nam JS, Hirohashi S and Wakefield LM:
Dysadherin: A new player in cancer progression. Cancer Lett.
255:161–169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Garty H and Karlish SJ: Role of FXYD
proteins in ion transport. Annu Rev Physiol. 68:431–459. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rajasekaran SA and Rajasekaran AK: Na,
K-ATPase and epithelial tight junctions. Front Biosci (Landmark
Ed). 14:2130–2148. 2009. View
Article : Google Scholar
|
|
34
|
Shin K, Fogg VC and Margolis B: Tight
junctions and cell polarity. Annu Rev Cell Dev Biol. 22:207–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Korsmeyer SJ, Shutter JR, Veis DJ, Merry
DE and Oltvai ZN: Bcl-2/Bax: A rheostat that regulates an
anti-oxidant pathway and cell death. Semin Cancer Biol. 4:327–332.
1993.PubMed/NCBI
|
